Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Zacks's profile

Blog
Gap (GAP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Gap (GAP) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended July 2025, Gap (GAP) reported revenue of $3.73 billion, up 0.1% over the same period last year. EPS came in at $0.57, compared to $0.54 in the year-ago quarter.

The reported

Ulta (ULTA) Reports Q2 Earnings: What Key Metrics Have to Say
Ulta (ULTA) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended July 2025, Ulta Beauty (ULTA) reported revenue of $2.79 billion, up 9.3% over the same period last year. EPS came in at $5.78, compared to $5.30 in the year-ago quarter.

The

Affirm Holdings (AFRM) Reports Q4 Earnings: What Key Metrics Have to Say
Affirm Holdings (AFRM) Reports Q4 Earnings: What Key Metrics Have to Say

Affirm Holdings (AFRM) reported $876.42 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 33%. EPS of $0.20 for the same period compares to -$0.14 a year

MakeMyTrip (MMYT) Stock Drops Despite Market Gains: Important Facts to Note
MakeMyTrip (MMYT) Stock Drops Despite Market Gains: Important Facts to Note

In the latest close session, MakeMyTrip (MMYT) was down 2.64% at $100.45. This change lagged the S&P 500's 0.32% gain on the day. Elsewhere, the Dow gained 0.16%, while the tech-heavy Nasdaq added

Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble

Thursday, August 28, 2025

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly